Our results suggested that Erianin inhibits GPX4 expression and promotes LPO and Fe2+ accumulation in RCC stem cells, i.e., Erianin might promote drug toxicity by inducing ferroptosis in RCC stem cells. Here, GPX4 is linked to renal cell carcinoma.